Chemed (CHE) PT Raised to $609 at RBC Capital
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $534.88 -0.15%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
RBC Capital analyst Frank Morgan raised the price target on Chemed (NYSE: CHE) to $609.00 (from $604.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS
- Marti Technologies (MRT) PT Lowered to $3.50 at Roth/MKM
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
